Normal Starting Dose of Topical Estradiol and Testosterone Cream
For postmenopausal women, start with transdermal estradiol at the lowest effective dose—typically 0.75 mg daily (via gel) or 50-100 mcg daily (via patch)—and titrate upward based on symptom response, not serum levels. For testosterone therapy in postmenopausal women with hypoactive sexual desire disorder, use 10 mg daily of topical testosterone cream applied to the skin, aiming to maintain physiologic premenopausal female testosterone concentrations 1, 2, 3.
Estradiol Dosing Strategy
Starting Doses by Formulation
The Endocrine Society guidelines emphasize using the lowest effective dose with upward titration based on clinical response 1. Specific starting doses include:
- Transdermal gel: 0.75-0.87 mg estradiol daily provides the lowest practical effective dose for vasomotor symptoms and vaginal atrophy 4, 5
- Transdermal patches: 50-100 mcg daily, with higher doses (100 mcg) reserved for younger women with surgical menopause or premature ovarian insufficiency who had higher baseline endogenous estradiol 1
- Vaginal estradiol (for local symptoms): 10 mcg tablet twice weekly after 2-week daily initiation, or low-dose vaginal ring 1
Key Dosing Principles
Do not routinely measure estradiol levels to monitor therapy except when symptoms fail to improve with escalating doses, particularly after switching from oral to transdermal routes 1. This is critical because there is substantial interindividual variation in absorption—one study found 25% of women on the highest licensed dose still had subtherapeutic levels 6.
For younger women with surgical menopause or premature ovarian insufficiency, start higher (transdermal estradiol 100 mcg) then slowly taper as tolerated, since these women are accustomed to higher baseline estradiol levels 1.
Route Selection Matters
Transdermal formulations are preferable for women with VTE risk, hypertension, hypertriglyceridemia, obesity, metabolic syndrome, diabetes, or gallbladder disease history, as they avoid first-pass hepatic metabolism that increases procoagulant effects, SHBG, triglycerides, and inflammatory markers 1.
Testosterone Dosing for Women
Evidence-Based Indication
The only evidence-based indication for testosterone in women is treatment of hypoactive sexual desire disorder (HSDD) in postmenopausal women after formal biopsychosocial assessment 2.
Starting Dose
Use 10 mg daily of topical testosterone cream applied to the skin 3. This dose significantly improved sexual desire, frequency, receptivity, and initiation in a randomized controlled trial without adverse effects over 3 months 3. Another study used 50 mg weekly transdermal testosterone (approximately 7 mg daily) combined with oral estrogen, showing significant improvement in Female Sexual Function Index scores 7.
Dosing Principles for Testosterone
The goal is to approximate physiologic testosterone concentrations for premenopausal women 2. Where female-specific testosterone preparations are unavailable, off-label prescribing of male formulations is reasonable provided hormone concentrations remain in the physiologic female range 2.
Important caveat: Most testosterone studies excluded women with hormone-sensitive breast cancer; use caution in this population 2.
Testosterone Dosing for Transgender Women (Context-Specific)
The FDA-approved testosterone gel 1.62% for male hypogonadism starts at 40.5 mg daily (2 pump actuations or one 40.5 mg packet) applied to shoulders and upper arms, with dose range of 20.25-81 mg daily 8. However, this is not applicable to transgender women seeking feminization, who require estradiol therapy instead.
For transgender women, recent evidence suggests guideline estradiol ranges (100-200 pg/mL) lack supporting data for optimal feminization 9, and there is substantial variation in estradiol absorption requiring individualized dosing 6, 10.
Critical Safety Considerations
For Estrogen Therapy
- Add progestogen in women with intact uterus to prevent endometrial hyperplasia and cancer 1
- Low-dose vaginal estrogen minimizes systemic absorption but long-term endometrial safety data beyond 1 year are lacking 1
- Avoid showering/swimming for at least 2 hours after gel application 8
For Testosterone Therapy
- Monitor for virilization signs (acne, hirsutism, voice deepening)
- Testosterone gel is flammable until dry 8
- Avoid skin-to-skin contact with others until application site is washed, as secondary exposure can cause virilization in children and partners 8